MindMuscle
Clinical-grade neurofeedback system for therapy clinics supporting children with ADHD and Autism.
Website: https://mindmuscle.health/
Cover Block
| Attribute | Details |
|---|---|
| Name | MindMuscle (a product of PigPug Health) |
| Tagline | Clinical-grade neurofeedback system for therapy clinics supporting children with ADHD and Autism. |
| Headquarters | Brooklyn, United States |
| Stage | Seed |
| Business Model | B2B |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Growth Profile | Venture Scale |
| Founding Team | Multi-Founder Team |
| Funding Label | Convertible Note |
Links
- Website: https://mindmuscle.health/
- LinkedIn: https://www.linkedin.com/company/pigpughealth
- Product Page: https://pigpug.co/mindmuscle/
Data Accuracy: GREEN -- Website and LinkedIn page confirmed via company sources; product page confirmed via PigPug Health domain.
What an Investor Needs First
MindMuscle is a clinical-grade neurofeedback system designed for therapy clinics to deliver structured, measurable support for children with ADHD and Autism [MindMuscle.health, retrieved 2024]. The company, a product of PigPug Health, has conducted a clinical study involving over 40 children and completed more than 400 therapy sessions [MindMuscle.health, retrieved 2024].
The founding team is led by CEO Vitali Karpeichyk [El Plural, retrieved 2024]. The company has secured early-stage capital through a convertible note with StartUp Health [Crunchbase, retrieved 2026].
Over the next 12-18 months, critical watchpoints include the publication of formal clinical trial results, securing regulatory clearances for its EEG device, and the transition from a study environment to commercial deployments within paying clinics. Expansion into sleep disorders, anxiety, and depression suggests a broader platform ambition [PIGPUG HEALTH, retrieved 2026].
Data Accuracy: YELLOW -- Core product claims and team structure are sourced from the company's own materials; funding details are partially corroborated by a single database.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Seed |
| Business Model | B2B |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Growth Profile | Venture Scale |
| Founding Team | Multi-Founder Team |
| Funding | Convertible Note |
Inside the Company
The operating entity behind the MindMuscle product is PigPug Health, headquartered in Brooklyn, New York [LinkedIn, retrieved 2026]. The founding team includes CEO Vitali Karpeichyk [El Plural, retrieved 2024]. Co-founders listed for PigPug Health include Andrei Pliachko as CAO and Brain Researcher and Juan Ricardo Diaz as a Neurofeedback Expert [pigpug.co/team/, retrieved 2026].
A key early milestone was a clinical study involving more than 40 children, during which the system completed over 400 therapy sessions [MindMuscle.health, retrieved 2024]. The company has secured early-stage financial backing from StartUp Health, structured as a convertible note [Crunchbase, retrieved 2026].
Data Accuracy: YELLOW -- Core company description and founder role are confirmed by company sources and LinkedIn. Funding details are partially corroborated by Crunchbase, but specific terms are not public.
Under the Hood
The core offering is a neurofeedback system combining a wearable EEG headset with adaptive software, designed for clinical use with children diagnosed with ADHD and Autism Spectrum Disorder (ASD) [MindMuscle.health, retrieved 2024]. The system captures brain activity, analyzes data in real time, and delivers immediate visual and auditory feedback to reinforce target brain states [MindMuscle.health, retrieved 2024].
Beyond the pediatric focus, PigPug Health markets the system for treating sleep disorders, anxiety, and depression [PigPug Health, retrieved 2026]. The company describes the system as "clinical-grade" and cites a clinical study involving over 40 children and the completion of more than 400 sessions [MindMuscle.health, retrieved 2024].
Data Accuracy: YELLOW -- Product claims are sourced from the company's website and parent company materials; clinical study metrics are self-reported and lack independent verification.
Market Research
The pediatric neurotherapy market is driven by rising diagnosis rates and a growing acceptance of non-pharmacological interventions. In the United States, approximately 1 in 36 children were identified with ASD in 2020, and about 6 million children aged 3-17 years had been diagnosed with ADHD as of 2019 [CDC, 2023]. The global digital therapeutics market for neurological disorders was valued at $3.4 billion in 2022 and is projected to grow at a compound annual rate of 26.1% through 2030 [Grand View Research, 2023].
| Metric | Value |
|---|---|
| U.S. Children with ADHD (diagnosed) | 6.0 million |
| U.S. Children with ASD (identified, 2020) | 2.8 million |
| Global Digital Therapeutics for Neurological Disorders (2022) | 3.4 $B |
| Projected CAGR (2023-2030) | 26.1 % |
Data Accuracy: YELLOW -- Market size figures are from third-party public health and market research reports, but specific TAM/SAM for the neurofeedback clinic segment is not confirmed.
Competition and Substitutes
MindMuscle operates at the intersection of pediatric behavioral health and consumer neurotechnology. The competitive map includes clinical-grade neurofeedback incumbents (e.g., NeuroField, NeuroPlus), consumer brain-training apps (e.g., EndeavorRx, Muse), and broader pediatric behavioral health platforms (e.g., Brightline, Mightier).
MindMuscle’s focus on the pediatric therapy clinic workflow and its cited study with 40+ children and 400+ sessions suggests early validation [MindMuscle.health, 2024]. However, the company lacks public FDA clearance or CE marking for its specific system. The single, undisclosed convertible note from StartUp Health [Crunchbase, 2026] indicates an early capital structure.
Data Accuracy: YELLOW - Competitive analysis is based on public positioning of known market players; specific competitive intelligence on MindMuscle’s market share or win/loss rates is not available.
Opportunity
The headline opportunity is to become the clinical-grade neurofeedback platform of record for pediatric behavioral health clinics. The company's focus on a structured, clinician-guided system positions it as a professional tool for therapists [MindMuscle.health, retrieved 2024].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Clinic-First Platform | The system becomes the default neurofeedback tool within a network of independent therapy clinics. | A partnership with a national clinic franchise or a large behavioral health group practice. | The product is already marketed to therapy clinics for structured support [MindMuscle.health, retrieved 2024]. |
| Research & Reimbursement | Publication of positive clinical trial data leads to insurance coverage. | Peer-reviewed publication of results from the initial 40+ child study. | The company has conducted a clinical study, indicating a research-oriented approach [MindMuscle.health, retrieved 2024]. |
Data Accuracy: YELLOW -- Core opportunity claims are based on company materials; growth scenarios are extrapolations from stated product focus.
Sources
- [MindMuscle.health, retrieved 2024] Home - MindMuscle | https://mindmuscle.health/
- [El Plural, retrieved 2024] Vitali Karpeichyk, CEO y fundador de MindMuscle: “Queremos ayudar a millones de niños a tener una vida mejor” - El Plural | https://www.elplural.com/el-telescopio/startup/vitali-karpeichyk-ceo-fundador-mindmuscle-queremos-ayudar-millones-ninos-tener-vida-mejor_388872102
- [LinkedIn, retrieved 2024] Vitali Karpeichyk - CEO at MindMuscle | Health Transformer | https://www.linkedin.com/in/vitali-karpeichyk/
- [PigPug Health, retrieved 2026] MINDMUSCLE - PIGPUG HEALTH | https://pigpug.co/mindmuscle/
- [Crunchbase, retrieved 2026] PigPug Health - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/pigpug
- [PIGPUG HEALTH, retrieved 2026] TEAM - PIGPUG HEALTH | https://pigpug.co/team/
- [LinkedIn, retrieved 2026] PigPug Health | LinkedIn | https://www.linkedin.com/company/pigpughealth
- [CDC, 2023] Data and Statistics on Autism Spectrum Disorder | https://www.cdc.gov/ncbddd/autism/data.html
- [Grand View Research, 2023] Digital Therapeutics Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/digital-therapeutics-market
- [American Medical Association, 2023] CPT® Evaluation and Management (E/M) Code and Guideline Changes | https://www.ama-assn.org/practice-management/cpt/cpt-evaluation-and-management-em-code-and-guideline-changes
Articles about MindMuscle
- MindMuscle's EEG Headset Aims for a New Kind of Pediatric Neurofeedback — The PigPug Health spinout is betting on a clinical-grade system for ADHD and autism, with early data from 40 children in a Brooklyn study.